Skip to main content
Top
Published in: Inflammation 2/2013

Open Access 01-04-2013

Mast Cells in Human Stenotic Aortic Valves Are Associated with the Severity of Stenosis

Authors: E. Wypasek, J. Natorska, G. Grudzień, G. Filip, J. Sadowski, A. Undas

Published in: Inflammation | Issue 2/2013

Login to get access

Abstract

Aortic valve stenosis (AS) is characterized by extensive calcification of the aortic valve leaflets and infiltration of inflammatory cells. Activated mast cells (MCs) may participate in the induction of fibrosis and calcification with ensuing valve stiffening. We sought to investigate whether the number of MCs within stenotic aortic valves is associated with the severity of AS. We studied 43 patients (19 men, 24 women) with dominant AS (age, 64.2 ± 5.9 years; mean transvalvular pressure gradient, 62.11 ± 24.47 mmHg) without atherosclerotic vascular disease, undergoing elective aortic valve replacement. MCs were detected in the excised valves by immunostaining. Aortic valves from five healthy subjects obtained on autopsy served as negative controls. The number of tryptase- and chymase-positive MCs was increased in AS valves compared with the control valves (6.9 [2.3–18.9]/mm2 vs. 0.7 [0–2.2]/mm2, P = 0.0001 and 3.2 [2.1–9.4]/mm2 vs. 0.3 [0–1.9]/mm2, P = 0.002, respectively). MCs that colocalized with macrophages and neovessels were detected mainly in the calcified regions of the leaflets. The number of MCs positively correlated with maximal (r = 0.73, P < 0.0001) and mean (r = 0.78, P < 0.0001) gradients and maximal aortic jet velocity (r = 0.68, P = 0.0005). An inverse correlation with aortic valve area (r = −0.71, P = 0.0001) was also observed. Multivariate regression analysis revealed that MC number and valve thickness were significantly associated with mean transvalvular gradient (R 2 = 0.74, P < 0.000001) in AS patients. Increased MC number within human stenotic aortic valves is associated with the severity of AS.
Literature
1.
go back to reference Olszowska, M. 2011. Pathogenesis and pathophysiology of aortic valve stenosis in adults. Polskie Archiwum Medycyny Wewnętrznej 121: 409–413.PubMed Olszowska, M. 2011. Pathogenesis and pathophysiology of aortic valve stenosis in adults. Polskie Archiwum Medycyny Wewnętrznej 121: 409–413.PubMed
2.
go back to reference Jian, B., N. Narula, Q.Y. Li, E.R. Mohler 3rd, and R.J. Levy. 2003. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. The Annals of Thoracic Surgery 75: 457–465.PubMedCrossRef Jian, B., N. Narula, Q.Y. Li, E.R. Mohler 3rd, and R.J. Levy. 2003. Progression of aortic valve stenosis: TGF-beta1 is present in calcified aortic valve cusps and promotes aortic valve interstitial cell calcification via apoptosis. The Annals of Thoracic Surgery 75: 457–465.PubMedCrossRef
3.
go back to reference Otto, C.M., J. Kuusisto, D.D. Reichenbach, A.M. Gown, and K.D. O’Brien. 1994. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90: 844–853.PubMedCrossRef Otto, C.M., J. Kuusisto, D.D. Reichenbach, A.M. Gown, and K.D. O’Brien. 1994. Characterization of the early lesion of ‘degenerative’ valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 90: 844–853.PubMedCrossRef
4.
go back to reference Helske, S., K.A. Lindstedt, M. Laine, M. Mäyränpää, K. Werkkala, J. Lommi, H. Turto, and M. Kupari. 2004. Induction of local angiotensin II-producing systems in stenotic aortic valves. Journal of the American College of Cardiology 44: 1859–1866.PubMedCrossRef Helske, S., K.A. Lindstedt, M. Laine, M. Mäyränpää, K. Werkkala, J. Lommi, H. Turto, and M. Kupari. 2004. Induction of local angiotensin II-producing systems in stenotic aortic valves. Journal of the American College of Cardiology 44: 1859–1866.PubMedCrossRef
5.
go back to reference Lindstedt, K.A., Y. Wang, N. Shiota, J. Saarinen, M. Hyytiäinen, J.O. Kokkonen, J. Keski-Oja, and P.T. Kovanen. 2001. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. The FASEB Journal 15: 1377–1388.CrossRef Lindstedt, K.A., Y. Wang, N. Shiota, J. Saarinen, M. Hyytiäinen, J.O. Kokkonen, J. Keski-Oja, and P.T. Kovanen. 2001. Activation of paracrine TGF-beta1 signaling upon stimulation and degranulation of rat serosal mast cells: a novel function for chymase. The FASEB Journal 15: 1377–1388.CrossRef
6.
go back to reference Pejler, G., E. Rönnberg, I. Waern, and S. Wernersson. 2010. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 17(115): 4981–4990.CrossRef Pejler, G., E. Rönnberg, I. Waern, and S. Wernersson. 2010. Mast cell proteases: multifaceted regulators of inflammatory disease. Blood 17(115): 4981–4990.CrossRef
7.
go back to reference Caughey, G.H. 2011. Mast cell proteases as protective and inflammatory mediators. Advances in Experimental Medicine and Biology 716: 212–234.PubMedCrossRef Caughey, G.H. 2011. Mast cell proteases as protective and inflammatory mediators. Advances in Experimental Medicine and Biology 716: 212–234.PubMedCrossRef
8.
go back to reference Zhang, W., A.L. Chancey, H.P. Tzeng, Z. Zhou, K.J. Lavine, F. Gao, N. Sivasubramanian, P.M. Barger, and D.L. Mann. 2011. The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 8: 2106–2116.CrossRef Zhang, W., A.L. Chancey, H.P. Tzeng, Z. Zhou, K.J. Lavine, F. Gao, N. Sivasubramanian, P.M. Barger, and D.L. Mann. 2011. The development of myocardial fibrosis in transgenic mice with targeted overexpression of tumor necrosis factor requires mast cell-fibroblast interactions. Circulation 8: 2106–2116.CrossRef
9.
go back to reference Helske, S., S. Syväranta, M. Kupari, J. Lappalainen, M. Laine, J. Lommi, H. Turto, M. Mäyränpää, K. Werkkala, P.T. Kovanen, and K.A. Lindstedt. 2006. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. European Heart Journal 27: 1495–1504.PubMedCrossRef Helske, S., S. Syväranta, M. Kupari, J. Lappalainen, M. Laine, J. Lommi, H. Turto, M. Mäyränpää, K. Werkkala, P.T. Kovanen, and K.A. Lindstedt. 2006. Possible role for mast cell-derived cathepsin G in the adverse remodelling of stenotic aortic valves. European Heart Journal 27: 1495–1504.PubMedCrossRef
10.
go back to reference Syväranta, S., S. Helske, M. Laine, J. Lappalainen, M. Kupari, M.I. Mäyränpää, K.A. Lindstedt, and P.T. Kovanen. 2010. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 1220–1227.PubMedCrossRef Syväranta, S., S. Helske, M. Laine, J. Lappalainen, M. Kupari, M.I. Mäyränpää, K.A. Lindstedt, and P.T. Kovanen. 2010. Vascular endothelial growth factor-secreting mast cells and myofibroblasts: a novel self-perpetuating angiogenic pathway in aortic valve stenosis. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 1220–1227.PubMedCrossRef
11.
go back to reference Kovanen, P.T., M. Kaartinen, and T. Paavonen. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92: 1084–1088.PubMedCrossRef Kovanen, P.T., M. Kaartinen, and T. Paavonen. 1995. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 92: 1084–1088.PubMedCrossRef
12.
go back to reference Teirstein, P., M. Yeager, P.G. Yock, and R.L. Popp. 1986. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. Journal of the American College of Cardiology 8: 1059–1065.PubMedCrossRef Teirstein, P., M. Yeager, P.G. Yock, and R.L. Popp. 1986. Doppler echocardiographic measurement of aortic valve area in aortic stenosis: a noninvasive application of the Gorlin formula. Journal of the American College of Cardiology 8: 1059–1065.PubMedCrossRef
13.
go back to reference Natorska, J., G. Marek, M. Hlawaty, J. Sadowski, W. Tracz, and A. Undas. 2011. Fibrin presence within aortic valves in patients with aortic stenosis: association with in vivo thrombin generation and fibrin clot properties. Thrombosis and Haemostasis 105: 254–260.PubMedCrossRef Natorska, J., G. Marek, M. Hlawaty, J. Sadowski, W. Tracz, and A. Undas. 2011. Fibrin presence within aortic valves in patients with aortic stenosis: association with in vivo thrombin generation and fibrin clot properties. Thrombosis and Haemostasis 105: 254–260.PubMedCrossRef
14.
go back to reference Lamprecht, M.R., D.M. Sabatini, and A.E. Carpenter. 2007. Cell Profiler: versatile software for automated biological image analysis. Biotechniques 42: 71–75.PubMedCrossRef Lamprecht, M.R., D.M. Sabatini, and A.E. Carpenter. 2007. Cell Profiler: versatile software for automated biological image analysis. Biotechniques 42: 71–75.PubMedCrossRef
15.
go back to reference Jeziorska, M., C. McCollum, and D.E. Woolley. 1997. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. The Journal of Pathology 182: 115–122.PubMedCrossRef Jeziorska, M., C. McCollum, and D.E. Woolley. 1997. Mast cell distribution, activation, and phenotype in atherosclerotic lesions of human carotid arteries. The Journal of Pathology 182: 115–122.PubMedCrossRef
16.
go back to reference Laine, P., A. Naukkarinen, L. Heikkilä, A. Penttilä, and P.T. Kovanen. 2000. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 101: 1665–1669.PubMedCrossRef Laine, P., A. Naukkarinen, L. Heikkilä, A. Penttilä, and P.T. Kovanen. 2000. Adventitial mast cells connect with sensory nerve fibers in atherosclerotic coronary arteries. Circulation 101: 1665–1669.PubMedCrossRef
17.
go back to reference Joghetaei, N., P. Akhyari, B.H. Rauch, P. Cullen, A. Lichtenberg, M. Rudelius, J. Pelisek, and R. Schmidt. 2011. Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model. The Journal of Thoracic and Cardiovascular Surgery 142: 191–198.PubMedCrossRef Joghetaei, N., P. Akhyari, B.H. Rauch, P. Cullen, A. Lichtenberg, M. Rudelius, J. Pelisek, and R. Schmidt. 2011. Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model. The Journal of Thoracic and Cardiovascular Surgery 142: 191–198.PubMedCrossRef
18.
go back to reference Tani, K., F. Ogushi, H. Kido, T. Kawano, Y. Kunori, T. Kamimura, P. Cui, and S. Sone. 2000. Chymase is a potent chemoattractant for human monocytes and neutrophils. Journal of Leukocyte Biology 67: 585–589.PubMed Tani, K., F. Ogushi, H. Kido, T. Kawano, Y. Kunori, T. Kamimura, P. Cui, and S. Sone. 2000. Chymase is a potent chemoattractant for human monocytes and neutrophils. Journal of Leukocyte Biology 67: 585–589.PubMed
19.
go back to reference Gordon, J.R. 2000. TGFbeta1 and TNFalpha secreted by mast cells stimulated via the FcepsilonRI activate fibroblasts for high-level production of monocyte chemoattractant protein-1 (MCP-1). Cellular Immunology 201: 42–49.PubMedCrossRef Gordon, J.R. 2000. TGFbeta1 and TNFalpha secreted by mast cells stimulated via the FcepsilonRI activate fibroblasts for high-level production of monocyte chemoattractant protein-1 (MCP-1). Cellular Immunology 201: 42–49.PubMedCrossRef
20.
go back to reference Galli, S.J., and M. Tsai. 2010. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. European Journal of Immunology 40: 1843–1851.PubMedCrossRef Galli, S.J., and M. Tsai. 2010. Mast cells in allergy and infection: versatile effector and regulatory cells in innate and adaptive immunity. European Journal of Immunology 40: 1843–1851.PubMedCrossRef
21.
go back to reference Bot, I., S.C. de Jager, A. Zernecke, K.A. Lindstedt, T.J. van Berkel, C. Weber, and E.A. Biessen. 2007. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apoE deficient mice. Circulation 115: 2516–2525.PubMedCrossRef Bot, I., S.C. de Jager, A. Zernecke, K.A. Lindstedt, T.J. van Berkel, C. Weber, and E.A. Biessen. 2007. Perivascular mast cells promote atherogenesis and induce plaque destabilization in apoE deficient mice. Circulation 115: 2516–2525.PubMedCrossRef
22.
go back to reference Galante, A., A. Pietroiusti, M. Vellini, P. Piccolo, G. Possati, M. De Bonis, R.L. Grillo, C. Fontana, and C. Favalli. 2001. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. Journal of the American College of Cardiology 38: 1078–1082.PubMedCrossRef Galante, A., A. Pietroiusti, M. Vellini, P. Piccolo, G. Possati, M. De Bonis, R.L. Grillo, C. Fontana, and C. Favalli. 2001. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. Journal of the American College of Cardiology 38: 1078–1082.PubMedCrossRef
23.
go back to reference Helske, S., R. Oksjoki, K.A. Lindstedt, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P.T. Kovanen. 2008. Complement system is activated in stenotic aortic valves. Atherosclerosis 196: 190–200.PubMedCrossRef Helske, S., R. Oksjoki, K.A. Lindstedt, J. Lommi, H. Turto, K. Werkkala, M. Kupari, and P.T. Kovanen. 2008. Complement system is activated in stenotic aortic valves. Atherosclerosis 196: 190–200.PubMedCrossRef
24.
go back to reference Wojta, J., C. Kaun, G. Zorn, M. Ghannadan, A.W. Hauswirth, W.R. Sperr, G. Fritsch, D. Printz, B.R. Binder, G. Schatzl, J. Zwirner, G. Maurer, K. Huber, and P. Valent. 2002. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100: 517–523.PubMedCrossRef Wojta, J., C. Kaun, G. Zorn, M. Ghannadan, A.W. Hauswirth, W.R. Sperr, G. Fritsch, D. Printz, B.R. Binder, G. Schatzl, J. Zwirner, G. Maurer, K. Huber, and P. Valent. 2002. C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils. Blood 100: 517–523.PubMedCrossRef
25.
go back to reference Warrier, B., R. Mallipeddi, P.K. Karla, and C.H. Lee. 2005. The functional role of C-reactive protein in aortic wall calcification. Cardiology 104: 57–64.PubMedCrossRef Warrier, B., R. Mallipeddi, P.K. Karla, and C.H. Lee. 2005. The functional role of C-reactive protein in aortic wall calcification. Cardiology 104: 57–64.PubMedCrossRef
Metadata
Title
Mast Cells in Human Stenotic Aortic Valves Are Associated with the Severity of Stenosis
Authors
E. Wypasek
J. Natorska
G. Grudzień
G. Filip
J. Sadowski
A. Undas
Publication date
01-04-2013
Publisher
Springer US
Published in
Inflammation / Issue 2/2013
Print ISSN: 0360-3997
Electronic ISSN: 1573-2576
DOI
https://doi.org/10.1007/s10753-012-9565-z

Other articles of this Issue 2/2013

Inflammation 2/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.